Table 1.
Subgroup analysis of prevalence of CT in the general population in 5 WHO regions
| WHO regions | Male (%, 95 CI) | Female (%, 95 CI) | χ2 | P | Total (%, 95 CI) |
|---|---|---|---|---|---|
| Americas | 4.5 (2.2–6.7) | 5.3 (3.6–7.1) | 9.06 | < 0.01 | 4.5 (3.1–5.9) |
| Europe | 2.5 (1.7–3.4) | 2.6 (1.7–3.6) | 0.20 | 0.68 | 2.7 (1.9–3.6) |
| Africa | 1.4 (0.4–2.4) | 3.8 (0.7–6.9) | 63.44 | < 0.01 | 2.6 (1.4–3.9) |
| Western Pacific | 2.4 (1.5–3.4) | 2.7 (1.7–3.6) | 1.46 | 0.23 | 2.6 (1.8–3.5) |
| South-East Asia | 1.2 (0.3–2.1) | 0.8 (0.2–1.3) | 0.82 | 0.47 | 0.8 (0.3–1.3) |
| Total | 2.6 (2.0–3.2) | 3.1 (2.5–3.8) | 10.38 | < 0.01 | 2.9 (2.4–3.5) |
CT Chlamydia trachomatis; WHO World Health Organization; CI Confidence interval